JWH-193
JWH-193 is a synthetic cannabinoid from the naphthoylindole family, which acts as a potent and selective CB2 receptor agonist with a Ki of 22nM, and has selectivity of around 200 times for CB2 over CB1 receptors. It was discovered by and named after, the researcher John W. Huffman.
Chemistry[edit]
JWH-193 is part of the naphthoylindole family of synthetic cannabinoids. It is a complex organic compound with the molecular formula C25H25NO2. The systematic (IUPAC) name of JWH-193 is 1-pentyl-3-(2-methoxyphenylacetyl)indole.
Pharmacology[edit]
JWH-193 acts as a potent and selective agonist for the peripheral cannabinoid (CB2) receptor, with a Ki of 22nM. It has around 200 times selectivity for CB2 over the central cannabinoid (CB1) receptor. This makes it a useful tool for scientific research into the function of the CB2 receptor, as it allows the receptor to be activated selectively without producing the psychoactive effects that are usually associated with activation of the CB1 receptor.
Legal Status[edit]
The legal status of JWH-193 varies by country. In some countries, it is a controlled substance, while in others it is legal to possess for personal use. It is important to check the specific laws in your country before possessing or using JWH-193.
See Also[edit]
References[edit]
This WikiMD article can only be edited by registered and verified editors. You can log in or register.
JWH-193[edit]
-
Diagram of the chemical structure of JWH-193 -
Chemical structure of 6-methyl-JWH-200
Sponsored Health Resource
W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
